You searched for Humanized antibody - Page 38 of 45

Best in Biotech 19 Sep 2024

Six immunology biotech companies revolutionizing immune treatments in 2024

…agonist antibody designed to regulate T-cell homeostasis by targeting PSGL-1. By binding PSGL-1, it could downregulate chronically activated T cells without altering the activity of resting and early-activated T cells,…

September 19, 2024 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 30 Dec 2024

Six biotech companies leading the way in India

…rapid identification of selective and potent monoclonal antibodies with the potential to enhance antibody-dependent cellular cytotoxicity (ADCC) activity. Zumutor’s lead candidate, ZM008, is a first-in-class monoclonal antibody that disrupts the…

December 30, 2024 - 8 minutesmins - By Willow Shah-Neville

News and Trends 12 Jul 2016

Which European Biotechs made it to the Billion-Euro Club in 2016?

…time) Founded: 1992 City: Munich (Germany) Mission: MorphoSys is a biopharmaceutical company with a rich pipeline of future therapeutic antibody products and a sustainable dual therapeutic business model. Comment: It’s…

July 12, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 20 Feb 2018

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

Phase I results show promise for a new treatment for atopic dermatitis that may become a strong competitor to the market leader, Humira. Morphosys and Galapagos are developing an antibody…

February 20, 2018 - 3 minutesmins - By Alexander Burik

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

…money to fund the preclinical development of antibody drugs for unspecified autoimmune diseases. The company will also expand its drug discovery efforts to other unspecified disease areas and grow its…

October 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Aug 2022

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

…issued two patents that will protect Arecor Therapeutics’ formulations of high-concentration adalimumab until 2038. The company made the announcement today (August 9). Monoclonal antibody Adalimumab, sold by AbbVie under the…

August 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…(BDCs) outperform ADCs? Bicycle Therapeutics is a company in Cambridge founded by one of the top biotech leaders in the UK’s golden triangle. Its unique technology to develop antibody-like bicyclic…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jul 2022

Boston startup bags $40M Series A to smash preclinical bottlenecks

…of the startup is a type of drugs called targeted effectors. This class, including cell engagers and antibody-drug conjugates, involves attaching a therapeutic payload onto a carrier molecule that delivers…

July 14, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Mar 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

…next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and…

March 14, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

…Rochester OKN-007 – Oblato, Inc ADCs: new treatments see encouraging results in clinic Another advancement in endometrial cancer research is the development of antibody drug conjugates (ADCs) that are “designed…

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

antibody drug conjugate adc small cancer treatment

News and Trends 14 Apr 2023

TORL BioTherapeutics launches with $158M to target cancer

…pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered in the laboratory of scientific co-founder Dennis Slamon, professor of medicine, and chief of the division of hematology/oncology at…

April 14, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

…antibody BI-1206, in non-Hodgkin’s lymphoma (NHL) and the anti-TNFR2 antibody BI-1808 in cutaneous T-cell lymphoma (CTCL). “We are delighted to conclude this agreement with the widely respected patient organization Leukemia…

January 18, 2023 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Six immunology biotech companies revolutionizing immune treatments in 2024

Six biotech companies leading the way in India

Which European Biotechs made it to the Billion-Euro Club in 2016?

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

Boston startup bags $40M Series A to smash preclinical bottlenecks

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

2024: a year of breakthroughs for endometrial cancer?

TORL BioTherapeutics launches with $158M to target cancer

BioInvent receives funding for blood cancer treatments

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!